Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Doan

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
BJU International|January 3, 2023
Median 4-year outcomes of salvage irreversible electroporation for localized radio-recurrent prostate cancerBart Geboers, Matthijs J Scheltema, Alexandar Blazevski, et al.
Science Advances|March 29, 2023
Aberrant cell state plasticity mediated by developmental reprogramming precedes colorectal cancer initiationPratyusha Bala, Jonathan P Rennhack, Daulet Aitymbayev, et al.
The Journal of Urology|August 10, 2022
Final Analysis of the Magnetic Resonance Imaging in Active Surveillance TrialPaul Doan, Matthijs J Scheltema, Amer Amin, et al.
The Journal of Urology|September 12, 2022
Reply by AuthorsPaul Doan, Matthijs J Scheltema, Amer Amin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 4, 2022
Robot-Assisted Prostate-Specific Membrane Antigen-Radioguided Surgery in Primary Diagnosed Prostate CancerWilliam Gondoputro, Matthijs J Scheltema, Alexander Blazevski, et al.
BJU International|December 10, 2022
Salvage irreversible electroporation for radio-recurrent prostate cancer - the prospective FIRE trialAlexandar Blazevski, Bart Geboers, Matthijs J Scheltema, et al.
European Urology Open Science|July 13, 2023
A Novel Risk Calculator Incorporating Clinical Parameters, Multiparametric Magnetic Resonance Imaging, and Prostate-Specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Risk Stratification Before Transperineal Prostate BiopsyBrian D Kelly, Gideon Ptasznik, Matthew J Roberts, et al.
BJU International|November 13, 2022
Synchronous vs independent reading of prostate-specific membrane antigen positron emission tomography (PSMA-PET) and magnetic resonance imaging (MRI) to improve diagnosis of prostate cancerPaul Doan, William Counter, Nathan Papa, et al.
Translational Andrology and Urology|November 16, 2023
<sup>68</sup>Ga-PSMA-PET/CT in addition to mpMRI in men undergoing biopsy during active surveillance for low- to intermediate-risk prostate cancer: study protocol for a prospective cross-sectional studyWilliam Gondoputro, Paul Doan, Athos Katelaris, et al.
Gastroenterology|July 9, 2025
Chemical Perturbations Impacting Histone Acetylation Govern Colorectal Cancer DifferentiationPornlada Likasitwatanakul, Zhixin Li, Paul Doan, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
BJU International|January 3, 2023
Median 4-year outcomes of salvage irreversible electroporation for localized radio-recurrent prostate cancerBart Geboers, Matthijs J Scheltema, Alexandar Blazevski, et al.
Science Advances|March 29, 2023
Aberrant cell state plasticity mediated by developmental reprogramming precedes colorectal cancer initiationPratyusha Bala, Jonathan P Rennhack, Daulet Aitymbayev, et al.
The Journal of Urology|August 10, 2022
Final Analysis of the Magnetic Resonance Imaging in Active Surveillance TrialPaul Doan, Matthijs J Scheltema, Amer Amin, et al.
The Journal of Urology|September 12, 2022
Reply by AuthorsPaul Doan, Matthijs J Scheltema, Amer Amin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 4, 2022
Robot-Assisted Prostate-Specific Membrane Antigen-Radioguided Surgery in Primary Diagnosed Prostate CancerWilliam Gondoputro, Matthijs J Scheltema, Alexander Blazevski, et al.
BJU International|December 10, 2022
Salvage irreversible electroporation for radio-recurrent prostate cancer - the prospective FIRE trialAlexandar Blazevski, Bart Geboers, Matthijs J Scheltema, et al.
European Urology Open Science|July 13, 2023
A Novel Risk Calculator Incorporating Clinical Parameters, Multiparametric Magnetic Resonance Imaging, and Prostate-Specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Risk Stratification Before Transperineal Prostate BiopsyBrian D Kelly, Gideon Ptasznik, Matthew J Roberts, et al.
BJU International|November 13, 2022
Synchronous vs independent reading of prostate-specific membrane antigen positron emission tomography (PSMA-PET) and magnetic resonance imaging (MRI) to improve diagnosis of prostate cancerPaul Doan, William Counter, Nathan Papa, et al.
Translational Andrology and Urology|November 16, 2023
<sup>68</sup>Ga-PSMA-PET/CT in addition to mpMRI in men undergoing biopsy during active surveillance for low- to intermediate-risk prostate cancer: study protocol for a prospective cross-sectional studyWilliam Gondoputro, Paul Doan, Athos Katelaris, et al.
Gastroenterology|July 9, 2025
Chemical Perturbations Impacting Histone Acetylation Govern Colorectal Cancer DifferentiationPornlada Likasitwatanakul, Zhixin Li, Paul Doan, et al.
Pageof 3